Literature DB >> 8828213

A newly identified immunodominant membrane protein (pMB67) involved in Mycoplasma bovis surface antigenic variation.

A Behrens1, F Poumarat, D Le Grand, M Heller, R Rosengarten.   

Abstract

Mycoplasma bovis is a bovine pathogen able to cause systemic disease. It possesses a series of prominent, structurally related yet clearly distinguishable membrane lipoproteins on the cell surface. These variable surface proteins (Vsps) undergo highly dynamic and spontaneous changes in size and expression and are key immunogenic components. They may play a critical role as mediators of adherence to host cells and in escaping immune destruction. In this report, we define a novel, Vsp-unrelated membrane protein also associated with M. bovis surface antigenic variation. This protein has an apparent molecular mass of 67,000 Da in the type strain PG45 and was designated pMB67. Immunological and biochemical characterization of pMB67 demonstrated that it: (i) contains a specific epitope, (ii) is not modified by lipid but does contain cysteine, (iii) does not contain a Vsp-like repetitive periodic protein structure, (iv) is a predominant antigen recognized during M. bovis infections, (v) undergoes a high rate of phase variation in vitro and (vi) is size-variable. These results showed that M. bovis employs two types of specialized membrane proteins for surface diversification. The pMB67 protein may be useful in diagnostic assays and as a vaccine component.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828213     DOI: 10.1099/00221287-142-9-2463

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  5 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

2.  Chronic pneumonia in calves after experimental infection with Mycoplasma bovis strain 1067: characterization of lung pathology, persistence of variable surface protein antigens and local immune response.

Authors:  Kathrin Hermeyer; Inka Buchenau; Anne Thomasmeyer; Berit Baum; Joachim Spergser; Renate Rosengarten; Marion Hewicker-Trautwein
Journal:  Acta Vet Scand       Date:  2012-02-04       Impact factor: 1.695

3.  Proteomics identification and characterization of MbovP730 as a potential DIVA antigen of Mycoplasma bovis.

Authors:  Farhan Anwar Khan; Gang Zhao; Yusi Guo; Muhammad Faisal; Jin Chao; Xi Chen; Chenfei He; Harish Menghwar; Rahim Dad; Muhammad Zubair; Changmin Hu; Yingyu Chen; Huanchun Chen; Zhang Rui; Aizhen Guo
Journal:  Oncotarget       Date:  2017-11-02

4.  Immunoproteomic identification of MbovP579, a promising diagnostic biomarker for serological detection of Mycoplasma bovis infection.

Authors:  Farhan Anwar Khan; Muhammad Faisal; Jin Chao; Kai Liu; Xi Chen; Gang Zhao; Harish Menghwar; Hui Zhang; Xifang Zhu; Muhammad Asif Rasheed; Chenfei He; Changmin Hu; Yingyu Chen; Eric Baranowski; Huanchun Chen; Aizhen Guo
Journal:  Oncotarget       Date:  2016-06-28

5.  Differential Immunoreactivity to Bovine Convalescent Serum Between Mycoplasma bovis Biofilms and Planktonic Cells Revealed by Comparative Immunoproteomic Analysis.

Authors:  Shengli Chen; Huafang Hao; Ping Zhao; Wenheng Ji; Mingxia Li; Yongsheng Liu; Yuefeng Chu
Journal:  Front Microbiol       Date:  2018-03-05       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.